Association of peptic ulcer with Helicobacter pylori and the recurrence rate. A three year follow-up study

S A Nanivadekar1, P D Sawant, H D Patel

  • 1Department of Gastroenterology, L.T.M. Medical College, Sion, Bombay.

Insights

Helicobacter pylori infection relapse significantly increases peptic ulcer recurrence. Studies show H. pylori eradication is crucial for preventing ulcer relapses and improving patient outcomes.

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Internal Medicine

Background:

  • Helicobacter pylori (H. pylori) is a primary cause of peptic ulcer disease, implicated in 70-100% of cases.
  • Recurrent H. pylori infections are frequently linked to ulcer relapses, necessitating effective management strategies.

Purpose of the Study:

  • To investigate the direct correlation between H. pylori infection relapse and the recurrence of peptic ulcers.
  • To quantify the increased risk of ulcer recurrence associated with H. pylori reinfection.

Main Methods:

  • A 3-year study diagnosed 137 peptic ulcer cases (121 duodenal, 16 gastric).
  • Of 117 H. pylori-positive patients, 66 were followed for 3 months to 3 years.
  • H. pylori relapse and ulcer recurrence were monitored through serial examinations.

Main Results:

  • H. pylori relapse occurred in 91 examinations, leading to ulcer recurrence in 58 cases (63%).
  • In contrast, only 6 out of 61 examinations without H. pylori relapse showed ulcer recurrence (10%).
  • The difference in ulcer recurrence rates between relapsed and non-relapsed H. pylori infections was statistically significant (P < 0.001).

Conclusions:

  • H. pylori infection relapse is a major determinant of peptic ulcer recurrence.
  • Effective eradication and prevention of H. pylori reinfection are critical for managing peptic ulcer disease and reducing relapse rates.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...